Heng Liu
Vermogen: 180 M $ op 30-09-2026
Vermogen: 180 M $ op 30-09-2026
Dr. Heng Liu is a Chairman & General Manager at LongBio Pharma (Suzhou) Co., Ltd. Dr. Liu was previously employed as a Deputy Director-Pre Clinical Research by Evive Biotechnology (Shanghai Ltd. and a Co-Founder by Pharmab, Inc. He received his undergraduate degree from Shenyang Pharmaceutical University and a doctorate degree from The State University of New York.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
17,78% | 06-07-2026 | 13.347.056 ( 17,78% ) | 180 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 2 |
|---|---|
The State University of New York
The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau